◆ Cell Technologies · Terminal

Two AI tools.
One integrated R&D workflow.

Discover therapeutic opportunities with Oracle. Design rigorous clinical trials and make GO/NO-GO decisions with Delfi. One-click handoff between them keeps your team aligned from market analysis to protocol synopsis.

◆ Continuous monitoring

Cell Technologies Intelligence

Track diseases, compounds, modalities, regulations and competitors. Click Run Intelligence to fetch the latest from ClinicalTrials.gov, PubMed and the open web in one cited briefing. Topics are saved to your account and feed into Delfi and Oracle as context.

Latest briefing
Previous runs

Both tools run entirely in your browser. Your API key and analysis history are stored locally — never on a server. Open either tool below to get started, or use the workflow at the bottom to see how they connect.

D
Delfi v9.1
AI Pharma Intelligence Platform
Clinical trial design, R&D decision reports with RAG risk scoring, regulatory pathway analysis, competitor intelligence, and pipeline orchestration — all backed by ICH/FDA/EMA guidance.
  • Trial Design — 14-section protocol synopses with appended CMC Risk Register
  • R&D Decision Report — 7-dimension GO/NO-GO with Path-to-Outcome panel
  • Regulatory Pathway — IND strategy, expedited program eligibility
  • Competitive Intelligence — landscape analysis and differentiation
Open Delfi →
Launch Delfi
O
Oracle v5.1
Stem Cell & Modality Intelligence
Disease & market analysis with multi-modality comparison, cell type QC, and full printable manufacturing plans with RAG risk assessment. Start from a disease or browse therapeutic areas by unmet need.
  • Market & Disease — therapeutic areas ranked by unmet need
  • Multi-Modality Analysis — cell therapy vs biologics vs gene therapy vs small molecule
  • Cell QC — release criteria for 7 cell types with RAG overlay
  • Manufacturing Plan — full printable CMC plan + 8-10 risk cards
Open Oracle →
Launch Oracle
◆ Integrated Workflow

From disease to trial design in one session

Use Oracle to identify the right modality and design the manufacturing plan, then hand off to Delfi for the full clinical protocol synopsis. The handoff carries the disease, modality, mechanism, manufacturing summary, and QC criteria directly into Delfi's Trial Design generator — no copy-paste between tools.

1
Discover
Pick a disease or browse therapeutic areas by unmet need in Oracle
2
Compare
Oracle compares 4-6 modality options and ranks by scientific fit
3
Plan
Generate full manufacturing plan with QC and RAG risk assessment
4
Design
Hand off to Delfi for full trial protocol + R&D decision report
Important — Please read. Cell Technologies' AI tools generate analyses, risk assessments, and recommendations using artificial intelligence. Despite automated auditing and quality controls, AI-generated output can contain errors, omissions, or inaccuracies. All output is provided for informational and decision-support purposes only and does not constitute regulatory, legal, medical, or scientific advice. Users must independently verify all information — including risk ratings, regulatory references, manufacturing parameters, and clinical recommendations — against primary sources and qualified professional judgment before relying on it or making any decision. Cell Technologies accepts no liability for any actions taken or decisions made on the basis of this output, and provides the platform without warranty of any kind. By using this platform you acknowledge and accept these terms.